Shiraz University of Medical Sciences Researchers Yield New Study Findings on Cancer Gene Therapy (Gene therapy in beta thalassemia: a review article).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Keywords: Anemia; Beta Thalassemia; Bioengineering; Biotechnology; Cancer; Cancer Gene Therapy; Clinical Trials and Studies; Congenital Anemia; Drugs and Therapies; Gene Therapy; Genetics; Globins; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemeproteins; Hemic and Lymphatic Diseases and Conditions; Hemoglobinopathies; Hemolytic; Oncology; Pharmaceuticals; Post-Trial Research; Proteins; Thalassemia; Therapy EN Anemia Beta Thalassemia Bioengineering Biotechnology Cancer Cancer Gene Therapy Clinical Trials and Studies Congenital Anemia Drugs and Therapies Gene Therapy Genetics Globins Health and Medicine Hematologic Diseases and Conditions Hematology Hemeproteins Hemic and Lymphatic Diseases and Conditions Hemoglobinopathies Hemolytic Oncology Pharmaceuticals Post-Trial Research Proteins Thalassemia Therapy 330 330 1 09/25/23 20230925 NES 230925 2023 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Investigators publish new report on cancer gene therapy. The first beta thalassemia gene therapy was performed in France in 2006, and in this clinical trial, the first patient with the E/b0 thalassemia was treated at the age of 18. Gene therapy is a new therapeutic option for beta thalassemia patients that induces the continuous expression of beta globin chains in the patient's hematopoietic stem cells. [Extracted from the article]
    • Abstract:
      Copyright of Cancer Gene Therapy Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)